Conquering Diseases

Study Of An Investigational Therapy For Early Stage Triple Negative Breast Cancer

Description

Seeking adults with early stage triple negative breast cancer for a study comparing a shorter chemo-immunotherapy to the usual therapy.

Overview

Participants in this study will be randomly assigned to get either chemo-immunotherapy for up to 6 cycles or the usual chemo-immunotherapy for 8 cycles before having the usual surgery and post-surgery treatment.

What we're hoping for

We are studying if a shorter chemo-immunotherapy is better, worse, or the same as the usual chemo-immunotherapy before surgery and post-surgery treatment for adults with early stage triple negative breast cancer.

Additional Information

ClinicalTrials.gov Identifier: NCT05929768

 Principal Investigator

Alice  Caffrey, MD

UMass Memorial Health

 Study Contact

The Cancer  Research Office

508-856-3216

Cancer.research@umassmed.edu

 Location

UMass Chan University Campus

55 Lake Ave North 

Worcester,MA 01655

508-856-8989